UTHR CFO sells 10,000 shares after option exercise
UNITED THERAPEUTICS Corp CFO and Treasurer James Edgemond reported a combination of option exercise and share sales in company stock.
Rhea-AI Filing Summary
UNITED THERAPEUTICS Corp CFO and Treasurer James Edgemond reported a combination of option exercise and share sales in company stock. He exercised stock options covering 10,000 shares of Common Stock at a strike price of $117.76 per share and, on the same date, executed open-market sales totaling 10,000 shares of Common Stock.
The sales were broken into multiple trades at weighted average prices generally in the mid‑$540 range per share, as detailed in the filing. According to the transaction summary, these moves result in a net disposition of 10,000 shares. The filing notes that the option exercise and subsequent share sales were carried out under a pre-arranged Rule 10b5-1 trading plan entered into by Edgemond on October 31, 2025.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 10,000 shares ($4.29M approx. pre-tax spread)
Exercise and Sale
12 txns
Insider
EDGEMOND JAMES
Role
CFO AND TREASURER
Sold
10,000 shs ($5.46M)
Approx. gross sale proceeds
$5.46M
Approx. exercise cost
$1.18M
Approx. pre-tax spread
$4.29M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option | 10,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 10,000 | $117.76 | $1.18M |
| Sale | Common Stock | 120 | $539.6393 | $65K |
| Sale | Common Stock | 480 | $541.1433 | $260K |
| Sale | Common Stock | 440 | $542.7769 | $239K |
| Sale | Common Stock | 1,086 | $544.1119 | $591K |
| Sale | Common Stock | 1,545 | $544.9442 | $842K |
| Sale | Common Stock | 1,129 | $545.8885 | $616K |
| Sale | Common Stock | 1,033 | $547.0035 | $565K |
| Sale | Common Stock | 2,749 | $548.0374 | $1.51M |
| Sale | Common Stock | 1,298 | $549.0586 | $713K |
| Sale | Common Stock | 120 | $550.4767 | $66K |
Holdings After Transaction:
Stock Option — 30,000 contracts (Direct);
Common Stock — 18,876 shares (Direct)
Footnotes (11)
- F1. This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025.
- F10. This transaction was executed in multiple trades at prices ranging from $548.55 to $549.48. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F11. This transaction was executed in multiple trades at prices ranging from $550.39 to $550.52. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2. This transaction was executed in multiple trades at prices ranging from $539.29 to $540.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3. This transaction was executed in multiple trades at prices ranging from $540.76 to $541.48. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4. This transaction was executed in multiple trades at prices ranging from $542.40 to $543.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5. This transaction was executed in multiple trades at prices ranging from $543.51 to $544.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6. This transaction was executed in multiple trades at prices ranging from $544.51 to $545.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7. This transaction was executed in multiple trades at prices ranging from $545.52 to $546.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8. This transaction was executed in multiple trades at prices ranging from $546.52 to $547.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9. This transaction was executed in multiple trades at prices ranging from $547.52 to $548.49. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Key Figures
Shares sold: 10,000 shares
Option exercise shares: 10,000 shares
Option strike price: $117.76 per share
+3 more
6 metrics
Shares sold
10,000 shares
Open-market Common Stock sales on 2026-06-04
Option exercise shares
10,000 shares
Stock options converted into Common Stock on 2026-06-04
Option strike price
$117.76 per share
Exercise price of stock options into Common Stock
Highest reported sale price
$550.48 per share
Weighted average sale price in one trade range
Lowest reported sale price
$539.29 per share
Low end of one disclosed trade price range
Net buy/sell shares
10,000 shares net sold
transactionSummary netBuySellShares
Key Terms
Rule 10b5-1 trading plan, stock options, weighted average price, derivative security, +1 more
5 terms
Rule 10b5-1 trading plan financial
"exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
stock options financial
"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
weighted average price financial
"The price reported above reflects the weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
derivative security financial
"Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did UNITED THERAPEUTICS (UTHR) CFO James Edgemond report?
CFO James Edgemond reported exercising options for 10,000 UNITED THERAPEUTICS shares and selling 10,000 shares in open-market trades. The activity reflects a net disposition of 10,000 shares, combining an option exercise with same‑day sales.
What stock options did the UNITED THERAPEUTICS (UTHR) CFO exercise?
He exercised stock options covering 10,000 UNITED THERAPEUTICS Common Stock shares with a strike price of $117.76 per share. This converted derivative holdings into common shares as part of the reported transactions.
Was the UNITED THERAPEUTICS (UTHR) CFO’s stock sale under a Rule 10b5-1 plan?
Yes. The filing states the option exercise and subsequent UNITED THERAPEUTICS share sales were executed pursuant to a Rule 10b5-1 trading plan entered into by the CFO on October 31, 2025, indicating a pre‑scheduled arrangement.
What does the transaction summary show for UNITED THERAPEUTICS (UTHR) CFO James Edgemond?
The transaction summary shows 10 sale transactions totaling 10,000 shares and one derivative exercise for 10,000 shares. Overall, it records a net-sell direction with netBuySellShares of 10,000 shares disposed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
